Biondo Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.1M | Sell |
24,929
-220
| -0.9% | -$97.9K | 1.46% | 24 |
|
2025
Q1 | $12.2M | Sell |
25,149
-131
| -0.5% | -$63.5K | 1.73% | 21 |
|
2024
Q4 | $10.2M | Buy |
25,280
+185
| +0.7% | +$74.5K | 1.4% | 26 |
|
2024
Q3 | $11.7M | Buy |
25,095
+665
| +3% | +$309K | 1.6% | 23 |
|
2024
Q2 | $11.5M | Buy |
24,430
+23,765
| +3,574% | +$11.1M | 1.7% | 17 |
|
2024
Q1 | $278K | Hold |
665
| – | – | 0.04% | 83 |
|
2023
Q4 | $271K | Hold |
665
| – | – | 0.05% | 71 |
|
2023
Q3 | $231K | Sell |
665
-100
| -13% | -$34.8K | 0.04% | 77 |
|
2023
Q2 | $269K | Hold |
765
| – | – | 0.05% | 73 |
|
2023
Q1 | $241K | Buy |
+765
| New | +$241K | 0.05% | 73 |
|
2021
Q2 | – | Sell |
-32,026
| Closed | -$6.88M | – | 88 |
|
2021
Q1 | $6.88M | Sell |
32,026
-37,342
| -54% | -$8.02M | 1.37% | 23 |
|
2020
Q4 | $16.4M | Buy |
69,368
+5,430
| +8% | +$1.28M | 3.14% | 8 |
|
2020
Q3 | $17.4M | Sell |
63,938
-915
| -1% | -$249K | 3.77% | 7 |
|
2020
Q2 | $18.8M | Sell |
64,853
-265
| -0.4% | -$76.9K | 4.75% | 5 |
|
2020
Q1 | $15.5M | Sell |
65,118
-1,552
| -2% | -$369K | 5.13% | 4 |
|
2019
Q4 | $14.6M | Buy |
66,670
+15,040
| +29% | +$3.29M | 3.37% | 8 |
|
2019
Q3 | $8.75M | Sell |
51,630
-4,220
| -8% | -$715K | 2.24% | 13 |
|
2019
Q2 | $10.2M | Buy |
55,850
+900
| +2% | +$165K | 2.43% | 10 |
|
2019
Q1 | $10.1M | Buy |
54,950
+8,930
| +19% | +$1.64M | 2.54% | 11 |
|
2018
Q4 | $7.63M | Buy |
46,020
+3,715
| +9% | +$616K | 2.3% | 12 |
|
2018
Q3 | $8.15M | Buy |
42,305
+7,785
| +23% | +$1.5M | 1.94% | 14 |
|
2018
Q2 | $5.87M | Buy |
34,520
+545
| +2% | +$92.6K | 1.48% | 20 |
|
2018
Q1 | $5.54M | Buy |
33,975
+4,720
| +16% | +$769K | 1.44% | 24 |
|
2017
Q4 | $4.38M | Buy |
29,255
+180
| +0.6% | +$27K | 1.11% | 30 |
|
2017
Q3 | $4.42M | Buy |
29,075
+26,075
| +869% | +$3.96M | 1.22% | 25 |
|
2017
Q2 | $387K | Buy |
+3,000
| New | +$387K | 0.11% | 69 |
|
2016
Q4 | – | Sell |
-43,612
| Closed | -$3.8M | – | 80 |
|
2016
Q3 | $3.8M | Buy |
+43,612
| New | +$3.8M | 1.29% | 27 |
|